Ruxolitinib dosing for acute graft‐versus‐host disease in a pediatric patient receiving continuous renal replacement therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ruxolitinib dosing for acute graft‐versus‐host disease in a pediatric patient receiving continuous renal replacement therapy

Published:2023-10-30 Issue:1 Volume:71 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Chen Teaghan T.¹^ORCID,David Alexandria P.¹,Gordon Sharon E.¹,McLaughlin Laura¹²

Affiliation:

1. Department of Pharmacy Aurora CO Children's Hospital Colorado Aurora Colorado USA

2. Department of Pediatrics Section of Hematology/Oncology and Bone Marrow Transplantation University of Colorado School of Medicine Aurora Colorado USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30754

Reference6 articles.

1. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

2. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

3. Ruxolitinib [package insert]. Incyte Corporation 2011.

4. Population pharmacokinetics of ruxolitinib in children with hemophagocytic lymphohistiocytosis: focus on the drug–drug interactions

5. The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP